Incidence and prognostic value of multiple gene promoter methylations in gliomas (Q44664373)

5 December 2017

title

Incidence and prognostic value of multiple gene promoter methylations in gliomas (English)

1 reference

5 December 2017

Longzhou Zhang

1

1 reference

5 December 2017

Maode Wang

series ordinal

2

1 reference

5 December 2017

Wei Wang

series ordinal

3

1 reference

5 December 2017

Jun Mo

series ordinal

4

1 reference

5 December 2017

publication date

6 November 2013

1 reference

Journal of Neuro-Oncology

5 December 2017

published in

1 reference

5 December 2017

volume

116

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

349-356

1 reference

DNA methylation analysis: a powerful new tool for lung cancer diagnosis

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

DNA hypermethylation in tumorigenesis: epigenetics joins genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Gene-promoter hypermethylation as a biomarker in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

CpG island hypermethylation in progression of esophageal and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Detection and quantification of mutations in the plasma of patients with colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Cells deficient in PARP-1 show an accelerated accumulation of DNA single strand breaks, but not AP sites, over the PARP-1-proficient cells exposed to MMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

DNA damage and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

The function of the protein tyrosine phosphatase SHP-1 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

JAK/STAT signal transduction: regulators and implication in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Molecular Classification of Low-Grade Diffuse Gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

The promise of pharmacogenetics: assessing the prospects for disease and patient stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11060-013-1301-5

Serum DNA as a tool for cancer patient management

21 January 2018

1 reference

12 December 2020

Circulating DNA and NSCLC: old findings with new perspectives.

1 reference

12 December 2020

Multimarker circulating DNA assay for assessing blood of prostate cancer patients

1 reference

12 December 2020

Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.

1 reference

12 December 2020

High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma

1 reference

12 December 2020

DNA methylation and cancer

1 reference

12 December 2020

Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma

1 reference

12 December 2020

Genetic variants in inflammation pathway genes and asthma in glioma susceptibility

1 reference

12 December 2020

Glioblastoma Multiforme Oncogenomics and Signaling Pathways

1 reference

12 December 2020

A gene hypermethylation profile of human cancer

1 reference

12 December 2020

PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?

1 reference

12 December 2020

The fundamental role of epigenetic events in cancer

1 reference

12 December 2020

10.1007/S11060-013-1301-5

Identifiers

DOI

1 reference

5 December 2017

1 reference